Recombinant MS4A1 (Rituximab Biosimilar) anticorps

N° du produit ABIN7581287

Cet anticorps anti-MS4A1 (Rituximab Biosimilar) est un anticorps Human Monoclonal détectant MS4A1 (Rituximab Biosimilar) dans FACS, ELISA, BLI, Func et SPR. Adapté pour Humain.

Aperçu rapide pour Recombinant MS4A1 (Rituximab Biosimilar) anticorps (ABIN7581287)

Antigène: MS4A1 (Rituximab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp MS4A1 (Rituximab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-MS4A1 (Rituximab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-CD20 / MS4A1 Reference Antibody (rituximab)

Séquence: QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYNMHWVKQT PGRGLEWIGA IYPGNGDTSY NQKFKGKATL TADKSSSTAY MQLSSLTSED SAVYYCARST YYGGDWYFNV WGAGTTVTVS AASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKAE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K,QIVLSQSPAI LSASPGEKVT MTCRASSSVS YIHWFQQKPG SSPKPWIYAT SNLASGVPVR FSGSGSGTSY SLTISRVEAE DAATYYCQQW TSNPPTFGGG TKLEIKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC

Attributs du produit: Anti-CD20 Reference Antibody (rituximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.32 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: CD20 inhibitors(B lymphocyte antigen CD20 inhibitors), ADCC(antibody-dependent cytotoxicity), CD20(targeted cytolysis)

Conditions: Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma Rheumatoid Arthritis (Anti-TNF Refractory) Vasculitis ANCA-associated

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur MS4A1 (Rituximab Biosimilar)

Antigène: MS4A1 (Rituximab Biosimilar)

Autre désignation: CD20 (Rituximab Biosimilar)

Classe de substances: Biosimilar

Sujet: Synonyms: Membrane-spanning 4-domains, subfamily A, member 1, MS4A1, B lymphocyte surface antigen B1, Leu-16, Bp35

Poids moléculaire: 146.32 kDa

UniProt: P11836